Goksu A, Dirol H, Kocanci F
Pharmacol Res Perspect. 2024; 12(5):e70018.
PMID: 39360479
PMC: 11447456.
DOI: 10.1002/prp2.70018.
Frohlich E
Int J Mol Sci. 2024; 25(5).
PMID: 38474149
PMC: 10931704.
DOI: 10.3390/ijms25052903.
Demirkol B, Gul S, Cortuk M, Akanil Fener N, Yavuzsan E, Eren R
Sarcoidosis Vasc Diffuse Lung Dis. 2023; 40(3):e2023036.
PMID: 37712376
PMC: 10540724.
DOI: 10.36141/svdld.v40i3.13847.
Santos-Ribeiro D, Lecocq M, De Beukelaer M, Bouzin C, Palmai-Pallag M, Yakoub Y
Pulm Circ. 2023; 13(1):e12177.
PMID: 36618712
PMC: 9817427.
DOI: 10.1002/pul2.12177.
Giuliano A, Almendros A
Animals (Basel). 2022; 12(18).
PMID: 36139200
PMC: 9495018.
DOI: 10.3390/ani12182340.
Fatty Acid Metabolism and Idiopathic Pulmonary Fibrosis.
Geng J, Liu Y, Dai H, Wang C
Front Physiol. 2022; 12:794629.
PMID: 35095559
PMC: 8795701.
DOI: 10.3389/fphys.2021.794629.
The immunopathology of lung fibrosis: amphiregulin-producing pathogenic memory T helper-2 cells control the airway fibrotic responses by inducing eosinophils to secrete osteopontin.
Hirahara K, Aoki A, Morimoto Y, Kiuchi M, Okano M, Nakayama T
Semin Immunopathol. 2019; 41(3):339-348.
PMID: 30968186
DOI: 10.1007/s00281-019-00735-6.
Histopathological Correlations between Mediastinal Fat-Associated Lymphoid Clusters and the Development of Lung Inflammation and Fibrosis following Bleomycin Administration in Mice.
Elewa Y, Ichii O, Takada K, Nakamura T, Masum M, Kon Y
Front Immunol. 2018; 9:271.
PMID: 29497425
PMC: 5818413.
DOI: 10.3389/fimmu.2018.00271.
Dexamethasone attenuates bleomycin-induced lung fibrosis in mice through TGF-β, Smad3 and JAK-STAT pathway.
Shi K, Jiang J, Ma T, Xie J, Duan L, Chen R
Int J Clin Exp Med. 2014; 7(9):2645-50.
PMID: 25356121
PMC: 4211771.
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?.
Moeller A, Ask K, Warburton D, Gauldie J, Kolb M
Int J Biochem Cell Biol. 2007; 40(3):362-82.
PMID: 17936056
PMC: 2323681.
DOI: 10.1016/j.biocel.2007.08.011.
Time course of bleomycin-induced lung fibrosis.
Izbicki G, Segel M, Christensen T, Conner M, Breuer R
Int J Exp Pathol. 2002; 83(3):111-9.
PMID: 12383190
PMC: 2517673.
DOI: 10.1046/j.1365-2613.2002.00220.x.
Modulation of bleomycin-induced pulmonary fibrosis in the BALB/c mouse by cyclophosphamide-sensitive T cells.
Schrier D, Phan S
Am J Pathol. 1984; 116(2):270-8.
PMID: 6205593
PMC: 1900549.
Drug-induced pulmonary fibrosis.
Adamson I
Environ Health Perspect. 1984; 55:25-36.
PMID: 6203733
PMC: 1568370.
DOI: 10.1289/ehp.845525.
Experimental bleomycin lung in mice. A contribution to the pathogenesis of pulmonary fibrosis.
FASSKE E, Morgenroth K
Lung. 1983; 161(3):133-46.
PMID: 6192292
DOI: 10.1007/BF02713855.
The effect of alpha-difluoromethylornithine on the development of bleomycin-induced pulmonary fibrosis in hamsters.
Giri S, Hyde D, Schwartz L, Younker W
Am J Pathol. 1982; 109(1):115-22.
PMID: 6181691
PMC: 1916055.
The role of soluble factors in bleomycin-induced pulmonary fibrosis.
Phan S, Thrall R
Am J Pathol. 1982; 106(2):156-64.
PMID: 6175217
PMC: 1916179.
Lung damage from cytotoxic drugs.
Collis C
Cancer Chemother Pharmacol. 1980; 4(1):17-27.
PMID: 6153937
DOI: 10.1007/BF00255453.
Pulmonary fibrosis following therapy with Melphalan for multiple myeloma.
Codling B, Chakera T
J Clin Pathol. 1972; 25(8):668-73.
PMID: 5076801
PMC: 477474.
DOI: 10.1136/jcp.25.8.668.
Diffuse pulmonary alveolar fibrosis.
Scadding J
Thorax. 1974; 29(3):271-81.
PMID: 4851389
PMC: 470146.
DOI: 10.1136/thx.29.3.271.
The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Adamson I, BOWDEN D
Am J Pathol. 1974; 77(2):185-97.
PMID: 4141224
PMC: 1910906.
